VAERS reports by lot

GSK Varicella/Shingles lot YS53Y: VAERS reports

77 VAERS reports list lot YS53Y as a GSK Varicella/Shingles vaccine, received between 2018-01-16 and 2019-01-23. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
77
Reports
12%
Marked serious
0
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)6829%
Injection-site / Local reaction5423%
Neurological2711%
Dermatological (non-injection-site)2611%
Musculoskeletal2511%
Allergic / Anaphylactic146%
Cardiac / Cardiovascular73%
Respiratory73%
Gastrointestinal73%
Psychiatric / Neuropsychiatric21%

Where reports came from

U.S. state of the reporter, where given (top 12).

New York9
California6
Illinois6
Texas5
Indiana4
New Jersey4
Maryland3
Washington3
South Carolina3
Oregon2
Colorado2
Nebraska2

Reports by month received

2018-015
2018-0211
2018-0319
2018-0413
2018-0512
2018-065
2018-078
2018-081
2018-091
2018-121
2019-011

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.